🔗 erdera.org
Co-funded by European Union's #HorizonEU Research & Innovation programme. Views expressed are of authors only.
Join 4 Task Forces/WGs on Digital Twins, Care Models, Data/Registries, Digital Biomarkers. Worldwide experts: researchers, clinicians, patients, regulators and the list goes on! 🔗 More: https://loom.ly/w_8lAvI #IRDiRC #RareDiseases
Join 4 Task Forces/WGs on Digital Twins, Care Models, Data/Registries, Digital Biomarkers. Worldwide experts: researchers, clinicians, patients, regulators and the list goes on! 🔗 More: https://loom.ly/w_8lAvI #IRDiRC #RareDiseases
Understanding our genetic origins is key to developing better treatments💡 Read #ERDERA’s Knowledge Pill on #DNA, genetic mutations, epigenetics, and inheritance—explained clearly and accessibly 🔗 https://loom.ly/HfZkiLw
Understanding our genetic origins is key to developing better treatments💡 Read #ERDERA’s Knowledge Pill on #DNA, genetic mutations, epigenetics, and inheritance—explained clearly and accessibly 🔗 https://loom.ly/HfZkiLw
Theme: Resolving unsolved cases in rare genetic and non-genetic diseases. 👉 Access the full details and criteria: https://loom.ly/YzdmNGY #ERDERA #RareDiseases #ResearchFunding
Theme: Resolving unsolved cases in rare genetic and non-genetic diseases. 👉 Access the full details and criteria: https://loom.ly/YzdmNGY #ERDERA #RareDiseases #ResearchFunding
Join the leading global event on drug repurposing to explore patient-centred innovation from AI and rare diseases to policy and funding.
Early Bird tickets out now ➡️ https://loom.ly/OLXLDNE
#RareDiseases #ERDERA
Join the leading global event on drug repurposing to explore patient-centred innovation from AI and rare diseases to policy and funding.
Early Bird tickets out now ➡️ https://loom.ly/OLXLDNE
#RareDiseases #ERDERA
🌍 Boosts inclusion of underrepresented countries
📅 Apply anytime – second deadline: 7 April 2026
🔗 https://loom.ly/scOFS9w
#ERDERA #ResearchFunding
🌍 Boosts inclusion of underrepresented countries
📅 Apply anytime – second deadline: 7 April 2026
🔗 https://loom.ly/scOFS9w
#ERDERA #ResearchFunding
This year’s theme: “Rare Diseases in a changing and competitive Europe: shaping policies to address the unmet needs of people living with rare diseases”
🔗 Info: https://loom.ly/kNumRPA
This year’s theme: “Rare Diseases in a changing and competitive Europe: shaping policies to address the unmet needs of people living with rare diseases”
🔗 Info: https://loom.ly/kNumRPA
Register now👇 https://loom.ly/E2cmGmM #RareDiseases
Register now👇 https://loom.ly/E2cmGmM #RareDiseases
The call “Resolving unsolved cases in rare genetic and non-genetic diseases” supports global research efforts to speed up diagnosis & improve outcomes. 🔗All the info is now available: https://loom.ly/YzdmNGY #ERDERA #RareDisease
The call “Resolving unsolved cases in rare genetic and non-genetic diseases” supports global research efforts to speed up diagnosis & improve outcomes. 🔗All the info is now available: https://loom.ly/YzdmNGY #ERDERA #RareDisease
ERDERA’s new call will focus on solving unsolved rare disease cases through variant validation and advanced technologies.
🔸Info: https://lnkd.in/erMJCeGn
🔸Register to the webinar: https://loom.ly/d45a8o8
#ERDERA
ERDERA’s new call will focus on solving unsolved rare disease cases through variant validation and advanced technologies.
🔸Info: https://lnkd.in/erMJCeGn
🔸Register to the webinar: https://loom.ly/d45a8o8
#ERDERA
👉 Secure your spot now: https://loom.ly/yceyPYw
👉 Find out more: https://loom.ly/1fhf8zI
👉 Secure your spot now: https://loom.ly/yceyPYw
👉 Find out more: https://loom.ly/1fhf8zI
Full programme & registration👉 https://loom.ly/1fhf8zI
🚨 Limited in-person spots available!
Full programme & registration👉 https://loom.ly/1fhf8zI
🚨 Limited in-person spots available!
1️⃣ Started with the first in-person meeting of the Multistakeholder Advisory Board
2️⃣ Continued with the open sessions on scientific advances & lived experiences
🔗 More: https://loom.ly/VXpdiqQ
1️⃣ Started with the first in-person meeting of the Multistakeholder Advisory Board
2️⃣ Continued with the open sessions on scientific advances & lived experiences
🔗 More: https://loom.ly/VXpdiqQ